Ravi Ravinuthala

2.3k total citations
4 papers, 112 citations indexed

About

Ravi Ravinuthala is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Ravi Ravinuthala has authored 4 papers receiving a total of 112 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Epidemiology, 3 papers in Hepatology and 1 paper in Infectious Diseases. Recurrent topics in Ravi Ravinuthala's work include Pneumocystis jirovecii pneumonia detection and treatment (2 papers), Liver Disease and Transplantation (2 papers) and Liver Diseases and Immunity (1 paper). Ravi Ravinuthala is often cited by papers focused on Pneumocystis jirovecii pneumonia detection and treatment (2 papers), Liver Disease and Transplantation (2 papers) and Liver Diseases and Immunity (1 paper). Ravi Ravinuthala collaborates with scholars based in United States and United Arab Emirates. Ravi Ravinuthala's co-authors include Mark Jonas, Guy Neff, Michael Jones, David M. Novick, Nyingi Kemmer, Tiffany E. Kaiser, Stephen H. Caldwell, Nikolaos Pyrsopoulos, Farheen Shaikh and Raj Vuppalanchi and has published in prestigious journals such as Journal of Hepatology and Journal of Clinical Gastroenterology.

In The Last Decade

Ravi Ravinuthala

4 papers receiving 110 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ravi Ravinuthala United States	4	80	76	50	17	16	4	112
David Toapanta Spain	6	65 0.8×	66 0.9×	27 0.5×	9 0.5×	21 1.3×	17	134
Nazım Ekin Türkiye	7	28 0.3×	37 0.5×	43 0.9×	26 1.5×	14 0.9×	21	113
Rebecca Saich United Kingdom	5	106 1.3×	79 1.0×	65 1.3×	17 1.0×	4 0.3×	8	163
John Almeida Australia	5	43 0.5×	45 0.6×	64 1.3×	30 1.8×	12 0.8×	8	172
Miquel Sanz Spain	5	81 1.0×	47 0.6×	46 0.9×	25 1.5×	3 0.2×	6	119
Girish S. Rao United States	5	76 0.9×	82 1.1×	25 0.5×	5 0.3×	17 1.1×	8	125
M.Á. Serra Spain	8	123 1.5×	147 1.9×	63 1.3×	18 1.1×	9 0.6×	17	209
Alina Zerega Argentina	9	210 2.6×	157 2.1×	65 1.3×	15 0.9×	10 0.6×	12	245
Haak Cheoul Kim South Korea	8	68 0.8×	82 1.1×	41 0.8×	20 1.2×	29 1.8×	14	163
José María Palazón Spain	6	106 1.3×	101 1.3×	43 0.9×	6 0.4×	8 0.5×	9	141

Countries citing papers authored by Ravi Ravinuthala

Since Specialization

Citations

This map shows the geographic impact of Ravi Ravinuthala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ravi Ravinuthala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ravi Ravinuthala more than expected).

Fields of papers citing papers by Ravi Ravinuthala

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ravi Ravinuthala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ravi Ravinuthala. The network helps show where Ravi Ravinuthala may publish in the future.

Co-authorship network of co-authors of Ravi Ravinuthala

This figure shows the co-authorship network connecting the top 25 collaborators of Ravi Ravinuthala. A scholar is included among the top collaborators of Ravi Ravinuthala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ravi Ravinuthala. Ravi Ravinuthala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Vuppalanchi, Raj, Stephen H. Caldwell, Nikolaos Pyrsopoulos, et al.. (2021). Proof-of-concept study to evaluate the safety and efficacy of saroglitazar in patients with primary biliary cholangitis. Journal of Hepatology. 76(1). 75–85. 50 indexed citations

2.

Neff, Guy, Michael Jones, Mark Jonas, et al.. (2013). Lack of Clostridium difficile Infection in Patients Treated With Rifaximin for Hepatic Encephalopathy. Journal of Clinical Gastroenterology. 47(2). 188–192. 22 indexed citations

3.

Neff, Guy, Michael Jones, Taylor Broda, et al.. (2011). Durability of Rifaximin Response in Hepatic Encephalopathy. Journal of Clinical Gastroenterology. 46(2). 168–171. 23 indexed citations

4.

Atiq, Muslim, Kamran Safdar, F Weber, et al.. (2008). Adult Onset Urea Cycle Disorder in a Patient With Presumed Hepatic Encephalopathy. Journal of Clinical Gastroenterology. 42(2). 213–214. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact